210 related articles for article (PubMed ID: 28262115)
1. Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).
Li J; Larregieu CA; Benet LZ
Chin J Nat Med; 2016 Dec; 14(12):888-897. PubMed ID: 28262115
[TBL] [Abstract][Full Text] [Related]
2. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
3. Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.
Benet LZ
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):162-7. PubMed ID: 20002064
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.
Golfar Y; Shayanfar A
J Pharm Pharm Sci; 2019; 22(1):247-269. PubMed ID: 31287788
[TBL] [Abstract][Full Text] [Related]
5. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
Hosey CM; Chan R; Benet LZ
AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
[TBL] [Abstract][Full Text] [Related]
6. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.
Bocci G; Oprea TI; Benet LZ
AAPS J; 2022 Feb; 24(2):37. PubMed ID: 35199251
[TBL] [Abstract][Full Text] [Related]
7. BDDCS class prediction for new molecular entities.
Broccatelli F; Cruciani G; Benet LZ; Oprea TI
Mol Pharm; 2012 Mar; 9(3):570-80. PubMed ID: 22224483
[TBL] [Abstract][Full Text] [Related]
8. Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS).
Ashrafi A; Teimouri K; Aghazadeh F; Shayanfar A
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):1-6. PubMed ID: 37864650
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
[TBL] [Abstract][Full Text] [Related]
10. Generative topographic mapping-based classification models and their applicability domain: application to the biopharmaceutics Drug Disposition Classification System (BDDCS).
Gaspar HA; Marcou G; Horvath D; Arault A; Lozano S; Vayer P; Varnek A
J Chem Inf Model; 2013 Dec; 53(12):3318-25. PubMed ID: 24320683
[TBL] [Abstract][Full Text] [Related]
11. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
Charalabidis A; Sfouni M; Bergström C; Macheras P
Int J Pharm; 2019 Jul; 566():264-281. PubMed ID: 31108154
[TBL] [Abstract][Full Text] [Related]
12. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.
Wu CY; Benet LZ
Pharm Res; 2005 Jan; 22(1):11-23. PubMed ID: 15771225
[TBL] [Abstract][Full Text] [Related]
13. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
14. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of DILI Predictive Hypotheses in Early Drug Development.
Chan R; Benet LZ
Chem Res Toxicol; 2017 Apr; 30(4):1017-1029. PubMed ID: 28257576
[TBL] [Abstract][Full Text] [Related]
16. Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System.
Liu W; Yan T; Chen K; Yang L; Benet LZ; Zhai S
Pharmacotherapy; 2020 Apr; 40(4):274-290. PubMed ID: 32100890
[TBL] [Abstract][Full Text] [Related]
17. In vitro disposition profiling of heterocyclic compounds.
Keemink J; Wuyts B; Nicolaï J; Jonghe SD; Stella A; Herdewijn P; Augustijns P; Annaert P
Int J Pharm; 2015 Aug; 491(1-2):78-90. PubMed ID: 26043826
[TBL] [Abstract][Full Text] [Related]
18. BDDCS applied to over 900 drugs.
Benet LZ; Broccatelli F; Oprea TI
AAPS J; 2011 Dec; 13(4):519-47. PubMed ID: 21818695
[TBL] [Abstract][Full Text] [Related]
19. Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems.
Idkaidek NM
Saudi Pharm J; 2014 Jan; 22(1):79-81. PubMed ID: 24493977
[TBL] [Abstract][Full Text] [Related]
20. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
Lindenberg M; Kopp S; Dressman JB
Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
